【摘要】 目的:观察用沙美特罗联合丙酸氟替卡松治疗儿童中度哮喘疗效。方法:选择我院2009年1月-2011年1月5～14岁符合中度哮喘诊断标准的患儿136例,随机分为沙美特罗联合丙酸氟替卡松治疗组68例与丙酸氟替卡松对照组68例,随访1年,观察无症状的时间、急诊就医次数及PEF(最大呼气流量)在治疗前后的变化。结果:治疗后治疗组无症状的时间、急诊就医次数及PEF的提高优于对照组,两组比较差异有显著统计学意义(P<0.01)。结论:沙美特罗联合丙酸氟替卡松治疗儿童中度哮喘疗效优于单独使用丙酸氟替卡松治疗。更多还原

【Abstract】 Objective:To observe the efficiacy of salmeterol and fluticasone propionate treating children with midrange asthma.Methods:Selected 136 cases with midrange asthma from January 2009 to January 2011 in our hospital.Those cases were divided into salmeterol groups and salmeterol added fluticasone propionate group.After followed-up 1 year,we surveyed their PEF variation before and after treatment.Results:After treatment the therapy group was superior to control group in some aspects,such as the times of enter emergence clinical,PEF and the no symptoms lifelong.Conclusion:The therapy of Salmeterol and fluticasone propionate is superior to salmeterol single therapy.更多还原